Browsing by Author Lee, Adrian

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 15 of 15
Issue DateTitleAuthor(s)Citation
2016The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trialsChan, David; Clarke, Stephen; Khasraw, Mustafa; Lee, Adrian; Li, Bob; Marx, Gavin; Pavlakis, Nick; Barnes, Tristan; Drilon, Alexander D.; Kris, Mark G.; Naidoo, Jarushka; Rudin, Charles M.; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Central Clinical School: Pathology; SAHCS: Medicine; Northern Clinical School: MedicineThe addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials, Lung Cancer, vol.102, N/A, 2016,pp 21-27
2015Attitudes and Barriers to Evidence-Based Practice in Optometry EducatorsTogher, Leanne; Challinor, Kirsten; Chiavaroli, Neville; Jalbert, Isabelle; Junghans, Barbara; Lee, Adrian; Pesudovs, Konrad; Stapleton, Fiona; Suttle, Catherine; Thompson, Rachel; Watt, Kathleen; Disability and CommunityAttitudes and Barriers to Evidence-Based Practice in Optometry Educators, Optometry and Vision Science, vol.92, 4, 2015,pp 514-523
2016Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trialBack, Michael; Khasraw, Mustafa; Lee, Adrian; Wheeler, Helen; Ackland, Stephen; Buyse, Marc E.; Kerestes, Z; Kichenadasse, G; McCowatt, Sally; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: MedicineCilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial, Journal of Neuro-Oncology, vol.128, 1, 2016,pp 163-171
2016Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trialBack, Michael; Khasraw, Mustafa; Lee, Adrian; Wheeler, Helen; Ackland, Stephen; Buyse, Marc E.; Kerestes, Z; Kichenadasse, G; McCowatt, Sally; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: MedicineCilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial, Journal of Neuro-Oncology, vol.128, 1, 2016,pp 163-171
2017Clinical use and interpretation of serum protein electrophoresis and adjunct assaysAdelstein, Stephen; Cassar, P; Johnston, Anna; Lee, Adrian; Central Clinical School: MedicineClinical use and interpretation of serum protein electrophoresis and adjunct assays, British Journal of Hospital Medicine, vol.78, 2, 2017,pp C18-C20
2017Early CCR6 expression on B cells modulates germinal centre kinetics and efficient antibody responsesFromm, Phillip; Bannan, Jennifer; Comerford, Iain; Kara, Ervin; Korner, Heinrich; Lee, Adrian; McColl, Shaun; Mielenz, Dirk; Reimer, Dorothea; Wiede, Florian; Concord Clinical School: ANZAC Research InstituteEarly CCR6 expression on B cells modulates germinal centre kinetics and efficient antibody responses, Immunology and Cell Biology, vol.95, 1, 2017,pp 33-41
2015HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinibCooper, Wendy Anne; Lee, Adrian; Li, B T; O'Toole, Sandra; Pavlakis, Nick; Yu, Bing; Arcila, Maria E; Chaft, Janie E; Kris, Mark G; Central Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Pathology; Northern Clinical School: Medicine; Central Clinical School: MedicineHER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib, Lung Cancer, vol.90, 3, 2015,pp 617-619
2016How has the Relevance of Institutional Brokerage Changed?Foster, Douglas; Fong, Kingsley; Gallagher, David; Lee, Adrian; FinanceHow has the Relevance of Institutional Brokerage Changed?, International Review of Finance, vol.16, 4, 2016,pp 499-524
2016How has the Relevance of Institutional Brokerage Changed?Foster, Douglas; Fong, Kingsley; Gallagher, David; Lee, Adrian; FinanceHow has the Relevance of Institutional Brokerage Changed?, International Review of Finance, vol.16, 4, 2016,pp 499-524
2014Identification of a Pathogenic Variant in TREX1 in Early-Onset Cerebral Systemic Lupus Erythematosus by Whole-Exome SequencingAlexander, Stephen; Andrews, T. Daniel; Cappello, Jean; Ellyard, Julia; et al, Various; Field, Matthew; Jerjen, Rebekka; Jiang, Simon; Lee, Adrian; Martin, Jamie; Naumann, Svenja; Scott, Hamish; Childrens Hospital Westmead: Paediatrics & Child HealthIdentification of a Pathogenic Variant in TREX1 in Early-Onset Cerebral Systemic Lupus Erythematosus by Whole-Exome Sequencing, Arthritis & Rheumatology, vol.66, 12, 2014,pp 3382-3386
2013Intensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single-institution seriesBack, Michael; Eade, Thomas; Guminski, Alexander; Lee, Adrian; Veivers, David; Guo, Linxin; Hanna, Catherine; Johnston, Meredith; Wignall, Andrew; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Medicine Faculty Office; Northern Clinical School: Medicine; Central Clinical School: MedicineIntensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single-institution series, Journal of Medical Imaging and Radiation Oncology, vol.57, 3, 2013,pp 356-363
2017Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare targetClarke, Stephen; Cooper, Wendy Anne; Gill, Anthony; Horvath, Lisa; Li, Bob; O'Toole, Sandra; Pavlakis, Nick; Yu, Bing; Kohonen-Corish, Maija R.J.; Lee, Adrian; Links, Matthew; Lum, Trina; Selinger, Christina; Tran, Thang N.; Yip, Po; Northern Clinical School: Kolling Institute; Central Clinical School: Medicine; Northern Clinical School: Pathology; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Pathology; Northern Clinical School: Medicine; Central Clinical School: MedicineScreening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target, Histopathology, vol.70, 3, 2017,pp 402-411
2016Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)Chan, David; Clarke, Stephen; Lee, Adrian; Li, Bob; Pavlakis, Nick; Wong, Matthew; Lumba, Sumit; Samra, Jas; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Central Clinical School: Pathology; Northern Clinical School: Medicine; MedicineSystematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET), PloS One, vol.11, 6, 2016,pp 1-15
2017Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine TumorsChan, David; Clarke, Stephen; Lee, Adrian; Li, Bob; Pavlakis, Nick; Samra, Jaswinder; Wong, Matthew; Lumba, Sumit; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Central Clinical School: Pathology; Northern Clinical School: Medicine; Northern Clinical School: Surgery; MedicineSystematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors, Neuroendocrinology, vol.104, 3, 2017,pp 209-222
2014Waiting costs and limit order book liquidity: Evidence from the ex-dividend deadline in AustraliaAinsworth, Andrew; Lee, Adrian; FinanceWaiting costs and limit order book liquidity: Evidence from the ex-dividend deadline in Australia, Journal of Financial Markets, vol.20, 1, 2014,pp 101-128